Cargando…

Global Immunization Challenge: Progress and Opportunities

After reading this chapter and answering the discussion questions that follow, you should be able to: Outline important milestones in the emergence of vaccines as a means of disease control and prevention. Discuss factors that underpin the disparity in access to vaccines between rich and poor countr...

Descripción completa

Detalles Bibliográficos
Autores principales: Affolder, Rebecca, Zaffran, Michel, Lob-Levyt, Julian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176199/
http://dx.doi.org/10.1007/b106524_23
_version_ 1783524974901854208
author Affolder, Rebecca
Zaffran, Michel
Lob-Levyt, Julian
author_facet Affolder, Rebecca
Zaffran, Michel
Lob-Levyt, Julian
author_sort Affolder, Rebecca
collection PubMed
description After reading this chapter and answering the discussion questions that follow, you should be able to: Outline important milestones in the emergence of vaccines as a means of disease control and prevention. Discuss factors that underpin the disparity in access to vaccines between rich and poor countries. Identify and appraise innovative options for financing vaccine development, and for ensuring wider access to new and underused vaccines in developing countries. Evaluate strategies for ensuring sustainability in vaccine development, management, and access. Outline priorities for future research, policy, and practice with regard to vaccine development, procurement, and access.
format Online
Article
Text
id pubmed-7176199
institution National Center for Biotechnology Information
language English
publishDate 2009
record_format MEDLINE/PubMed
spelling pubmed-71761992020-04-22 Global Immunization Challenge: Progress and Opportunities Affolder, Rebecca Zaffran, Michel Lob-Levyt, Julian Maternal and Child Health Article After reading this chapter and answering the discussion questions that follow, you should be able to: Outline important milestones in the emergence of vaccines as a means of disease control and prevention. Discuss factors that underpin the disparity in access to vaccines between rich and poor countries. Identify and appraise innovative options for financing vaccine development, and for ensuring wider access to new and underused vaccines in developing countries. Evaluate strategies for ensuring sustainability in vaccine development, management, and access. Outline priorities for future research, policy, and practice with regard to vaccine development, procurement, and access. 2009-05-18 /pmc/articles/PMC7176199/ http://dx.doi.org/10.1007/b106524_23 Text en © Springer Science+Business Media, LLC 2009 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Affolder, Rebecca
Zaffran, Michel
Lob-Levyt, Julian
Global Immunization Challenge: Progress and Opportunities
title Global Immunization Challenge: Progress and Opportunities
title_full Global Immunization Challenge: Progress and Opportunities
title_fullStr Global Immunization Challenge: Progress and Opportunities
title_full_unstemmed Global Immunization Challenge: Progress and Opportunities
title_short Global Immunization Challenge: Progress and Opportunities
title_sort global immunization challenge: progress and opportunities
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176199/
http://dx.doi.org/10.1007/b106524_23
work_keys_str_mv AT affolderrebecca globalimmunizationchallengeprogressandopportunities
AT zaffranmichel globalimmunizationchallengeprogressandopportunities
AT loblevytjulian globalimmunizationchallengeprogressandopportunities